Sankyo Pharma Inc. Release: New Study Demonstrates Co-Administration Of WelChol(R) (colesevelam HCI) And TriCor(R) (fenofibrate tablets) Resulted In No Significant Drug-Drug Interactions
10/19/2005 5:11:50 PM
More...
|
Kirin Brewery Co., Ltd. (KNBWY) , Sankyo Company, Ltd. (SKXOF.PK) To Terminate Joint Marketing Of Renal Anemia Drug ESPO And Leukopenia Drug GRAN By Next March
10/19/2005 5:11:50 PM
More...
|
Sankyo Pharma GmbH Simplifying Clinical Trial Communications With IntraLinks, Inc.; Pharma Leader To Manage Document Flow For ROADMAP Trial In More Than 22 European Countries
10/19/2005 5:09:53 PM
More...
|